One of the retinoic acid-inducible cDNA clones in mouse embryonal carcinoma F9 cells encodes a novel isoenzyme of fructose 1,6-bisphosphatase  by Nomura, Midori et al.
FEBS Letters 348 (1994) 201-205 
FEBS 14222 
One of the retinoic acid-inducible cDNA clones in mouse embryonal 
carcinoma F9 cells encodes a novel isoenzyme of fructose 
1,6_bisphosphatase 
Midori Nomuraa, Yoshihiro Takihara”, Teruo Yasunagab, Kazunori Shimada” 
aDepartment of Medical Genetics, Division of ~o~ecuiar 3iomedi~ine. Research Institute for Microbial Diseases, Osaka University, 3-l Yamadaoka. 
Suita, Osaka 565, Japan 
bGenome Information Research Center, Osaka University, 3-1 Yamadaoka, Suita, Osaka 565, Japan 
Received 23 May 1994 
Abstract 
Rae-30, one of the retinoic acid (RA)-inducible cDNA clones in mouse embryonal carcinoma F9 cells, was sequenced and the deduced RAE-30 
protein showed about a 70% homology to mammalian fructose 1,6-bisphosphatase (EC 3.1.3.11) (FBPase), in comparison to over 85% homology 
observed among the previously documented rat liver, pig kidney and human leukemic HL-60 cell FBPases. The Rae-30 mRNAs were not detected 
in various tissues of adult mice, including the liver and kidney, but were detected in a placenta nd pr~ominantly in the intestine of adult mice. These 
findings indicate that the Rae-30 cDNA encodes a novel isoenzyme of FBPase, which is likely to be involved in early differentiation in mammalian 
Cells. 
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1. Introduction 
Mouse embryonal carcinoma F9 cells closely resemble 
pluripotent embryonic stem cells in terms of morphol- 
ogy, bioch~ical characte~stics and growth properties 
[1,2]. F9 cells differentiate into parietal endoderm-like 
cells in response to retinoic acid (RA) [2,3]. This system 
provides a pertinent model for analyses of early differen- 
tiation in mammalian cells [l]. 
To elucidate molecular regulatory mechanisms in- 
volved in early mammalian development, we isolated a 
series of cDNA clones corresponding to those genes, the 
expression of which increases during RA-induced F9 cell 
differentiation [4]. We reported that one of the RA- 
inducible cDNA clones, named Rae-30 (retinoic acid 
early inducible cDNA clone-30), encodes a protein 
highly homologous to human fructose-1,6-bisphos- 
phatase (o-fructose- 1,6-bisphosphate l-phosphohydro- 
lase; EC 3.1.3.11) (FBPase) [4], an essential enzyme in 
gluconeogenesis [5]. 
We have now characterized the expression patterns of 
Rae-30 mRNAs and determined the entire nucleotide 
sequence of Rae-30 cDNA. We found that the Rae-30 
cDNA encodes a novel isoenzyme of FBPase, probably 
an intestinal FBPase. The Rae-30 cDNA should be use- 
ful not only to examine the relationship between struc- 
*Corresponding author, Fax: (81) (6) 879-8326. 
ture and function of the impo~ant metabolic isoen- 
zymes, but also to examine regulatory mechanisms 
functioning in early differentiation in mammalian cells. 
2. Materials and methods 
2. I. Cells 
Mouse embryonal carcinoma F9 cells were maintained in Dulbecco’s 
modified Eagle’s medium supplemented with 15% fetal calf serum, and 
were induced to differentiate by treatment with low6 M retinoic acid 
(RA) (Sigma) 121. 
2.2. RNA preparation and RNA analysis 
Total cellular RNA was extracted from F9 cells, intestines, 14-day 
embryos and placentas of BALBlc mice by the acid ~a~dini~ thio- 
cyanate-phenol-chloroform ethod [6]. Poly(A)’ RNA was prepared 
on an oligo(d~~llulo~ column. For RNA blot analysis, 1Opg of total 
cellular RNA was denatured with glyoxal, fractionated by 1% agarose 
gel electrophoresis and transferred to a nylon membrane 171. RNA blots 
were hybridized with ‘*P-labeled Rae-30 cDNA probe prepared by a 
multiprime DNA labeling system purchased from Amersham 181. 
2.3. Cloning and DNA sequence analysis 
Isolation of Rae-30 cDNA clone was as described previously [4]. 
pBluescript plasmids containing the Rae-30 cDNAs were excised from 
1ZAPII cDNA clones by co-infection with helper phage (Stratagene) 
and were used for DNA sequencing reactions, after subcloning the 
restriction endonuclea~ fragments into pBluesc~pt plasmid. The DNA 
sequence was determined by the dideoxy chain termination method 
adapted for denatured plasmid templates, using as primers T3 and T7 
oligonucleotides [9]. 
A DNA homology search was done using the FASTA and BLASTN 
programs and the non-r~undant nucleic acid database, and the de- 
duced protein homology search was done using the FASTA and 
BLASTX programs and the non-redundant protein database, respec- 
tively, at the Human Genome Center, Tokyo, Japan [lo]. 
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3. Results 
3.1. Expression of Rae-30 mRNA 
In our previous paper [4], we described that Rae-30 
cDNA encodes a protein highly homologous to a human 
FBPase, a regulatory enzyme in gluconeogenesis [5], 
and described the following observations: (1) Rae-30 
mRNAs are not detected in undifferentiated F9 cells; 
(2) they are induced at about 12 h after RA treatment, 
and are increased until 72 h; and (3) they are not detected 
in various tissues of adult mice, including the liver, kid- 
ney, and skeletal muscle. 
We confirmed that the Rae-30 mRNAs are not de- 
tected in undifferentiated F9 cells, but are expressed at 
high levels at 72 h of RA treatment (Fig. 1). Interestingly, 
we found that the Rae-30 mRNAs are not present in a 
l4-day embryo but are present in the placenta and pre- 
dominantly in the intestine of adult mice (Fig. 1). To 
determine whether gluconeogenetic pathways are acti- 
vated during RA-induced F9 cell differentiation, we ana- 
lyzed the patterns of expression of phosphoenolpyruvate 
carboxykinase (PEPCK), another enzyme essential for 
gluconeogenesis [ 111. Although PEPCK expression has 
been reported to be induced in rat hepatoma cells by RA 
treatment [l 11, we found no evidence for PEPCK mRNA 
either in undifferentiated or in RA-treated F9 cells (data 
not shown). These results suggest hat gluconeogenesis 
is not activated during the F9 cell differentiation. 
3.2. Sequence analysis of Rae-30 cDNA 
The entire nucleotide sequence of Rae-30 cDNA was 
dete~ined and the amino acid sequence of RAE-30 pro- 
tein was deduced (Fig. 2). The Rae-30 cDNA contained 
an open reading frame of 354 amino acids with a pre- 
dicted molecular weight of about 39 kDa. The reading 
frame was preceded by a typical Kozak initiation se- 
quence (CACAATGA) [12] and was terminated by a 
TGA stop codon. In the 3’-noncoding region, one puta- 
tive polyadenylation signal sequence AATAAA was 
present. These findings indicate that the Rae-30 cDNA 
probably corresponds to the almost full-length Rae-30 
mRNA (Fig. 2). 
3.3. Homologies between the mammalian FBPase and the 
deduced mouse RAE-30 protein 
~omolo~ search showed that the deduced RAE-30 
protein is highly homologous to mammalian FBPase 
(Fig. 3>, which catalyzes the hydrolysis of fructose 1,6- 
bisphosphate to fructose 6-phosphate and inorganic 
phosphate [5]. This enzyme is involved in many different 
metabolic pathways and is present in most organisms [5]. 
The amino acid sequences of FBPases from rat liver, pig 
kidney and human leukemic HL-60 ceils were deter- 
mined directly or were deduced from corresponding 
DNA sequence [13,14,15]. The deduced amino acid se- 
quence of RAE-30 protein was aligned with those of 
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Fig. I. Northern blot analysis of Rae-30 mRNAs. Total cellular RNAs 
were extracted from F9 cells after treatment with RA for 0 and 72 h, 
and from placenta, embryo and intestine of adult mice. Ten fig each of 
these RNAs was analyzed by RNA blotting using “P-labeled Rae-30 
cDNA as a probe. The intensity of GAPDH mRNA is shown in the 
lower part of the figure, as a control for the amount of RNA loaded 
in each lane. Symbols are as follows: 0 = control F9 cells; 72 = F9 cells 
treated with RA for 72 h: P = ICday placentas; E = 14-day embryos; 
I = intestines of adult mice. 
mammalian FBPases (Fig. 3). The alignment revealed a 
high sequence homology throughout the entire se- 
quences, except for the C-terminal region consisting of 
about 40 amino acids. This region is poorly conserved 
among the 4 proteins. 
The activity of mammalian FBPase is controlled by 
the action of two inhibitors, fructose 2,6-bisphosphate 
and AMP [5]. In X-ray crystallographic studies, 18 
amino acid residues have been located at or near the 
binding site of fructose 2,6-bisphosphate (see Fig. 3, res- 
idues marked with n) [16]. These 18 residues probably 
participate in active site interactions, and lysine-275 has 
been reported to be involved in catalytic mechanisms 
1161. All these 18 residues and the region around the 
lysine-275, from residues 274 to 284, G-K-L-R-L-L-Y-E- 
C-N-P, is completely conserved among these four differ- 
ent proteins (Fig. 3). Twelve amino acid residues have 
been reported to interact with AMP (see Fig. 3, residues 
marked with *) [17], and 10 of the 12 residues were 
conserved between the mammalian FBPase and RAE-30 
protein (Fig. 3). All these features indicate that the RAE- 
30 protein is an isoenzyme of mammalian FBPase. 
3.4. Evolution of the mouse RAE-30 gene 
The sequence homology among the ma~alian 
FBPases was over 85% in comparison to about 70% 
homology between the mammalian FBPase and the 
RAE-30 protein (Fig. 4A). We constructed a phylogen- 
etic tree to elucidate an evolutionary relationship be- 
tween mouse RAE-30 protein and mammalian FBPase 
(Fig. 4B). The tree indicated that the gene for mouse 
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MTDRSPFETDMLTL 14 
1 TTGGGATCTCATWGCAC~~ACGGACAGAAGCCCCTTTGAGACAGACATGCTGACCCT 
TRYVMEKGRQAKGTGELTQL 34 
61 GACCCGTTACGTTATGGAAAAGGGGCGACAGGCCAAAGGGACCGGAGAACTCACCCAGCT 
LNSMLTAIKAISSAVRKAGL 54 
121 GCTCAACTCGATGCTGAC'I'XCATCAAAGCCATCTCTTCCGCAGTGCGCAAGGCCGGCCT 
ANLYGISGSVNVTGDEVKKLl4 
181 GGCCAACC'IGTATGGGAT'R'CGGGGAGCGTGAATGTGACAGGAGATGAGGTGAAGAAACT 
DVLSNSLVINMLQSSYSTCV 94 
241 GGACGTGCTGTCCAACTCCCTGGTCATCAACATGCTTCAGTCCTCCTACAGCACCTfXGT 
LV S E ENK EAV I TAQ E R RG K Y 114 
301 ~~GTC~CG~GAG~T~GA~C~~A~ACA~CCA~AGA~A~~TA 
VVC F D P L DG S S N I DC L A S I G134 
361 ~~~~ACCC~~A~A~~~~A~AC~CC~CTCCATC~ 
T I F A I Y R K TT E D E P S E K DA L154 
421 AACTATA'KTTGCTATR'ACAGAAAGACCACGGAGGACGAGCCT'XTGAGAAGGATGCCTT 
Q P G RN I VAAGYALYG S RT LV I.74 
481 GCAGCCTGGCCGCAACATCGlGGCTGCGGGTl'ATGCACTGTATGGTAGTCGAACCC'IGGT 
AL S TGQGVDL FML D P ALG E F194 
541 l-GCTCTl-TCCACAGGACAAGGAGTGGATCTG~CA'l'GCTGGACCCGGCTC~AGAATT 
VLV E KDVR I KKKG K I F S LN E 214 
601 CGTGCTAGTGGAXiAAGATGTCCGGATTAAGAAGAAAGGGAAAATTl-TTAGCCTCAACGA 
G Y AKY F DAATAEYVQ K KK F P 234 
661 GGGCTATGCCAAGTAT'MTGATGCXXTACTGC'PGACC 
E DG S E PYGARYVGSMVADVH 254 
721 CGAGGATGGCAGTGAGCCTAGCCAGGTACGTGGGTTCCAlK%TGGC'IGA'IGTGCA 
RTLVYGG I FMY P ANQK S PNG 274 
781 TCGCACCTTGGTCTA'IGGAGGAATCTTCATGTACCCAGCC~CCAGAAGAGTCCTAATGG 
K L R L LY E C N PVAY I I E Q AG G 294 
841 CAAGCTCCGGCTCCTGTATGAATGCAATCCTG~CCTATATCATCGAGCAAGCAGGAGG 
MATTGTQPVLDVKPES I H Q R 314 
901 TA~C~CCACAffiCA~CCAGCCAGTAC~A~~~CC~AGAGTA~ACC~G 
VP L I LG PLRMCKS I SAVC R E 334 
961 AGTCCCCC~A~~~CCC~A~A~~C~GAGTA~~AGC~~~AGAGA 
TRQAG S E P E PMS PLP FVFVN 354 
1021 AACCAGGCAGGCAGGTAGTCCTGAACCCATGAGCCCCGCTTCCCTTTGTCTTT'GTCAA 
TER 
1081 ~_$AAACTAGATGAAGCTATGGAGATGGGAGGAAAGGCiUAGAAGTCiUG~ACA 
1141 CAGGTCACGGTCAGAACAGCGCCCTGCTGCTAAGGACAGGGTTAGAAGCCAGGGGTAAAG 
1201 AAAGATACAGTCTTTGGACT nq8BTBBBAAATGAATC"AA 
Fig. 2. The nucleotide and amino acid sequence structures of Rae-30 cDNA. (A) A cleavage map of the Rae-30 cDNA. The restriction sites: P = PvuII; 
B = B&I; E = EcoRI; N = NcaI; S = ScaI. The putative coding regions are shaded. (B) The nucleotide and deduced amino acid sequences of Rae-30 
cDNA. A putative initiation ATG codon in the 5’-noncoding region, a termination codon and a polyadenylation signal sequence in the 3’noncodmg 
regions are double-underlined. The predicted amino acid sequence is shown above the nucleotide sequence. The numbers at the left and right sides 
denote that of nucleotides and amino acids, respectively. 
RAE-30 protein diverged from an ancestoral gene of 
mammalian FBPase 174 million years ago if we take a 
divergence time between human and rodents as 75 mil- 
lion years ago [18]. This suggests that the counterpart of 
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* l ***** 
1 MADQAPFDTD VNTLTRFVME EGRKARG'TGE LTQLLNSLCT AVKAISSAVR human 
1 -T...A...N IV........ . . . . . . . . . . M......... . . . . ..T... Picl 
1 -v H...E.. IS......L. . . . ..G.... M......... .I........ rat 
1 .T.RS..E.. ML....y... K..Q.K.... . . . . . . . ML. .I........ RAE-30 
A AA 
51 KAGIAHLYGI AGSTNVTGDQ VKKLDVLSND LVMNNLKSSF ATCVLVSEED human 
50 . . . . . . . . . ..I.V..... 
50 6::::;:::: :::::::::: :....*.... ..I......Y 
. . . . . . . . . . pig 
. . . . . . . . . . rat 
51 . ..L.N.... S..V..... E . . . . . . . ..s ..I...Q..Y S.... . . ..N RAE-30 
** A A A * 
101 KHAIIVEPEK RGKYWCFDP LDGSSNIDCL VSVGTIFGIY RKKSTDEPSE human 
100 .N........ . . ..I.__.. t......... . . . ,.....‘ .* N . ..*.._ pig 
100 T....I.... ..I....... . . . . . . . . . . A.I....... ..T.AN.... rat 
101 .E.V.TAQ.R .,........ . . . . . . . . . . A.I....A.. ..TTE..... RAE-30 
* l 
151 KDALQPGRNL VAAGYALYGS ATMLVLAMDC GVNCFMLDPA IGEFILVDKD human 
150 . . . . . . . . . . . . . . . . . . . . . . . . . . ..VN . . . . . . . . . . . . . . . . . . R. pig 
150 . . . . . . . . . . . . . . .._... . . . . . . ..N. *......*. s . . . . . . . . R. rat 
151 . . . . . . . ..I . . . . . . . . . . R.LVA.STGQ ..DL...... L...V..E.. RAE-30 
A A MAM 
201 VKIKKKGKIY SLNEGYAKDF DPAVTEYIQR KKFPPDNSAP YGARYVGSMV human 
200 . . . . . ..S.. .I......E. . ..I...... . . . . . . . . . . . . . . ...**. pig 
200 . . . . . ..N.. .I,....... . ..IN..... . . . . . . . . . . . . . . . . . . . . rat 
201 .R.......F . . . . . . ..Y. .A.TA..V.K . . ..E.G.E. . . . . . . . . . . RAE-30 
A A AA A 
251 ADVHRTLVYG GIFLYPANKK SPNGKLRLLY ECNPMAYVME KAGGMATTGK human 
250 . . . . . . . . . . . ..M...... ..K....... . . . . . . . . . . . . . . L . . . . . pig 
250 . . . . . . . . . . . . . . . . . . . . N.S....... . . ..I..... . . ..L....N rat 
251 . . . . . . . .._ . ..M....Q. . . . . . . . . . . . . ..V..II. Q........T RAE-30 
301 EAVLDVIPTD IHQRAPVILG SPDDVLEFLK VYEKHSAQ-- ---------- human 
300 . . . ..IV... . . . . ..I... ..E..T.L.E I.Q..A.K-- ---------- pig 
300 .DI..IV..E . ..K....M. .TE..Q...E I.N.DK.KSR PSLPLPQSRA rat 
301 QP....K.ES . . ..V.L... PLRMCKSISA .CRETRQAGS EPEPM----- RAE-30 
__---~~_-- -__ human 
___--____- -__ pig 
350 RESPVHSICD ELF rat 
346 --SPLPFVFV N-- RAE-30 
Fig. 3. Alignments of the amino acid sequences among mammalian FBPase and RAE-30 protein. Complete deduced amino acid sequence of RAE-30 
protein is shown in lines labeled with RAE-30 at the right. The amino acid sequences of human FBPase, pig FBPase, rat FBPases and RAE-30 protein 
are shown in lines labeled with human, pig, rat and RAE-30 at the right, respectively. Dots indicate identical amino acid residues and dashes, insertions 
made during alignment. The amino acid residues marked with A have been located at or near the binding site of fructose 2,6-bisphosphate [ 161, and 
those marked with * interact with AMP 1171. The numbers at the left denote amino acid residue numbers. 
mouse RAE-30 protein exists in every mammalian spe- 
cies. 
4. Discussion 
We have characterized Rae-30, one of the RA-induci- 
ble cDNA clones in F9 cells, and found that although 
Rae-30 mRNAs are not detected in various tissues of 
adult mice, including the liver, kidney and skeletal mus- 
cle [4], they are present in the placenta and predomi- 
nantly in the intestine of adult mice (Fig. 1). In response 
to RA, the Rae-30 mRNAs are induced in F9 cells (Fig. 
1) [4], and F9 cells are induced to differentiate into pari- 
eta1 endoderm-like cells, one of the major cell lineages of 
the placenta [2,3]. These observations indicate that the 
pattern of expression of Rae-30 mRNAs represents an 
event occurring in mammalian cells during early differ- 
entiation, and indicate that the Rae-30 cDNA provides 
one model system to examine the developmental stage- 
specific and tissue-specific transcriptional regulation. 
The deduced RAE-30 protein showed about a 70% 
homology with three different mammalian FBPases (Fig. 
4). ~a~alian FBPase activities were predominantly 
present in liver, kidney and skeletal muscle [19]. Signifi- 
cant activity was also observed in the small intestinal 
mucosa of adult mice 1191. As the intestinal FBPase was 
lo-fold more sensitive to AMP inhibition than the liver 
enzyme, they were thought to represent different isoen- 
zymes [19]. However, the amino acid sequence of the 
intestinal FBPase has not been reported, and the cDNA 
and genomic DNA structures have not been elucidated. 
The alignments of amino acid sequences of the deduced 
RAE-30 protein and the three different mammalian 
FBPases indicated that the Rae-30 cDNA encodes a 
novel isoenzyme of FBPase (Fig. 3). We speculate that 
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Fig. 4. (A) A scheme showing the degree of sequence homology among 
the RAE-30 protein and mammalian FBPases. Symbols: human, pig 
and rat indicate FBPases from human leukemic HL-60 cells, pig kidney 
and rat liver, respectively; RAE-30 indicates the deduced RAE-30 pro- 
tein of the mouse. The numbers indicate the amino acid sequence 
homology in %, calculated from the sequence data summarized in Fig. 
3. (B) Phylogenetic relationship of mouse RAE-30 protein and mam- 
malian FBPases. Amino acid sequence difference (d) for each pair of 
RAE-30, human FBPase, pig FBPase and rat FBPase was calculated 
and corrected for multiple hits to get a number of amino acid substitu- 
tions per site (k) by the equation, k = -log(l -d) [22]. For this calcula- 
tion, amino acids from #2 to #338 of human FBPase and RAE-30 
protein and those from #l to #337 ofpig and rat FBPases in Fig. 3 were 
used. Phylogentic tree was constructed by the unweighted pair-group 
clustering method [23]. 
this isoenzyme corresponds to intestinal FBPase [19], 
because the Rae-30 mRNAs are detected at high levels 
in the intestine (Fig. l), but not in the liver, kidney and 
skeletal muscle of adult mice [4]. 
A striking deficiency of hepatic FBPase activity was 
demonstrated in a child with hypoglycemia and meta- 
bolic acidosis on fasting [20]. A sibling who died with 
similar features suggested that this is an inherited defect 
[20]. However, the roles of the RAE-30 protein as well 
as those of the intestinal FBPase remain to be elucidated. 
To construct the RAE-30 protein-deficient mice by gene 
targeting [21] will shed light not only on regulatory 
mechanisms of gluconeogenesis, but also on the regula- 
tory mechanisms of early differentiation in mammalian 
cells. 
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